Vascular tumors of intermediate malignancy: An update.
Hum Pathol
; 147: 114-128, 2024 May.
Article
in En
| MEDLINE
| ID: mdl-38360216
ABSTRACT
The term "hemangioendothelioma" is used for endothelial neoplasms of intermediate malignancy and describes a group of rare neoplasms having biologic behavior falling in between that of the benign hemangiomas and fully malignant angiosarcomas. The hemangioendotheliomas fall into several specific, clinicopathologically and genetically distinct entities, specifically epithelioid hemangioendothelioma, kaposiform hemangioendothelioma, papillary intralymphatic angioendothelioma and retiform hemangioendothelioma (hobnailed hemangioendothelioma), pseudomyogenic hemangioendothelioma, composite hemangioendothelioma, and YAP1TFE3-fused hemangioendothelioma. The clinical, morphologic, immunohistochemical, and genetic features, and the differential diagnosis of each of these rare entities are discussed in this review.
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Biomarkers, Tumor
/
Hemangioendothelioma
Limits:
Humans
Language:
En
Journal:
Hum Pathol
/
Hum. pathol
/
Human pathology
Journal subject:
PATOLOGIA
Year:
2024
Document type:
Article
Country of publication:
Estados Unidos